BIOGEN IDEC
Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues.
BIOGEN IDEC
Social Links:
Industry:
Biotechnology Health Care Neuroscience Therapeutics
Founded:
1978-01-01
Address:
Weston, Massachusetts, United States
Country:
United States
Website Url:
http://www.biogen.com
Total Employee:
5001+
Status:
Active
Contact:
(781) 464-2000
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Content Delivery Network Domain Not Resolving Apache Mobile Non Scaleable Content Euro Organization Schema IPv6
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
MBF Bioscience
MBF Bioscience is a biotechnology firm that provides imaging software for stereology, neuron reconstruction, and image analysis.
Current Advisors List
Franca Herwig Manager Digital HCP Service Platforms @ Biogen Idec Board_member 2020-09-01
Robert W. Pangia Board of Director @ Biogen Idec Board_member
Lynn Schenk Member of the Board of Directors @ Biogen Idec Board_member
Richard C. Mulligan Board of Director @ Biogen Idec Board_member
Brian Posner Board of Directors @ Biogen Idec Board_member
Alexander J. Denner Board of Director @ Biogen Idec Board_member
Eric Rowinsky Member of the Board of Directors @ Biogen Idec Board_member 2010-01-01
George Scangos Member of Board of Directors @ Biogen Idec Board_member
Current Employees Featured
Deborah Glasser
Deborah Glasser Associate Director - BG12 HCP Marketing @ Biogen Idec Associate Director - BG12 HCP Marketing 2011-10-01
Jaren Landen
Jaren Landen Early Alzheimer's Disease Head @ Biogen Idec Early Alzheimer's Disease Head 2020-10-01
David Kolwyck
David Kolwyck Director Manufacturing Science - Raw Materials @ Biogen Idec Director Manufacturing Science - Raw Materials 2014-12-01
Elodie Cramer
Elodie Cramer Head of Strategic Sourcing @ Biogen Idec Head of Strategic Sourcing 2013-06-01
Yizhou Zhou
Yizhou Zhou Head of Cell Line Technology, Gene Therapy Development @ Biogen Idec Head of Cell Line Technology, Gene Therapy Development 2022-01-01
Georgia Mitsi
Georgia Mitsi GM Mental Health & VR solutions @ Biogen Idec GM Mental Health & VR solutions 2021-06-01
Firoz Antia
Firoz Antia Executive Director, Head of Oligonucleotide Development @ Biogen Idec Executive Director, Head of Oligonucleotide Development 2021-12-01
Baohong Zhang
Baohong Zhang Head of Genome Informatics @ Biogen Idec Head of Genome Informatics 2018-08-01
Priya Singhal
Priya Singhal Head, SVP, Global Safety & Regulatory Sciences @ Biogen Idec Head, SVP, Global Safety & Regulatory Sciences 2020-02-01
Joel Schwartz
Joel Schwartz Sr. Manager @ Biogen Idec Sr. Manager 2018-08-01
Founder
Bernard Mach
Jeff Behrens
Phillip Sharp
Stock Details
Company's stock symbol is NASDAQ:BIIB
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-03-04 | Nightstar Therapeutics | Nightstar Therapeutics acquired by Biogen Idec | N/A |
2017-05-18 | Remedy Pharmaceuticals | Remedy Pharmaceuticals acquired by Biogen Idec | 120 M USD |
2015-01-11 | Convergence Pharmaceuticals | Convergence Pharmaceuticals acquired by Biogen Idec | 675 M USD |
2014-02-14 | Stromedix | Stromedix acquired by Biogen Idec | 75 M USD |
2013-02-01 | Tysabri | Tysabri acquired by Biogen Idec | N/A |
2007-01-04 | Syntonix Pharmaceuticals | Syntonix Pharmaceuticals acquired by Biogen Idec | 120 M USD |
2006-05-31 | Fumapharm | Fumapharm acquired by Biogen Idec | N/A |
2006-05-03 | Conforma Therapeutics | Conforma Therapeutics acquired by Biogen Idec | 150 M USD |
2003-06-24 | IDEC Pharmaceuticals | IDEC Pharmaceuticals acquired by Biogen Idec | 6.4 B USD |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-08 | Autobahn Therapeutics | Biogen Idec investment in Venture Round - Autobahn Therapeutics | 32.7 M USD |
2020-11-27 | SAGE Therapeutics | Biogen Idec investment in Post-IPO Equity - SAGE Therapeutics | 650 M USD |
2020-06-11 | Autobahn Therapeutics | Biogen Idec investment in Series B - Autobahn Therapeutics | 76 M USD |
2020-01-13 | CAMP4 Therapeutics | Biogen Idec investment in Venture Round - CAMP4 Therapeutics | 15 M USD |
2018-06-28 | Samsung Bioepis | Biogen Idec investment in Venture Round - Samsung Bioepis | 748.6 B KRW |
2017-10-25 | Neurimmune Holding | Biogen Idec investment in Venture Round - Neurimmune Holding | 150 M USD |
2017-03-30 | Solid Biosciences | Biogen Idec investment in Series C - Solid Biosciences | 50 M USD |
2016-01-06 | Rodin Therapeutics | Biogen Idec investment in Series B - Rodin Therapeutics | 17.3 M USD |
2014-06-17 | True North Therapeutics | Biogen Idec investment in Series A - True North Therapeutics | 22 M USD |
2014-03-17 | Ataxion | Biogen Idec investment in Series A - Ataxion | 17 M USD |
Newest Events participated
Participated in 14th Annual International Pediatric Orthopaedic Symposium
on 2017-11-28 as sponsor
Participated in North Carolina Science Festival
on 2015-04-10 as sponsor
Official Site Inspections
http://www.biogen.com
- Host name: ec2-54-198-120-92.compute-1.amazonaws.com
- IP address: 54.198.120.92
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
Loading ...